Month: April 2021

IRVINE, Calif., April 19, 2021 (GLOBE NEWSWIRE) — Lantronix, Inc. (the “Company”) (NASDAQ: LTRX), a global provider of Software as a Service (SaaS), connectivity services, engineering services, intelligent hardware and turnkey solutions for the Internet of Things (IoT) and Remote Environment Management (REM), today announced it will release financial results for its fiscal 2021 third quarter ended March 31, 2021, on April 29, 2021, after the close of the market. Management will host an investor conference call and audio webcast at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on April 29, 2021. To access the live conference call, investors should dial 1-844-802-2442 (US) or 1-412-317-5135 (international) and indicate that they are participating in the Lantronix Q3 FY 2021 call. The webcast will be available simultaneously via...

Not for distribution to United States newswire services or for dissemination in the United States. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. TORONTO, April 19, 2021 (GLOBE NEWSWIRE) — Automotive Finco Corp. (TSX-V: AFCC) (“AFCC” or the “Company”) today announces that, further to its news releases dated February 16, 2021 and April 7, 2021, the TSX Venture Exchange (the “Exchange”) advises that the Company has not satisfied the Tier 2 CLR and its listing on the Exchange will be transferred by the Exchange to the NEX board (the “NEX”) effective at the opening of trading on April 21, 2021. The Company’s shares will continue to trade under the symbol AFCC but with the extension (.H). The symbol extension differentiates NEX symbols from Tier...

COLUMBIA, Md., April 19, 2021 (GLOBE NEWSWIRE) — W. R. Grace & Co. (NYSE:GRA), the leading independent supplier of polyolefin catalyst technology and polypropylene (PP) process technology, has licensed its UNIPOL® PP Process Technology and its UNIPOL UNIPPAC® Process Control Software to Sinochem Hongrun Petrochemical Chemical Co., Ltd. (Sinochem Hongrun). The UNIPOL® PP facility, located in Qingzhou, Weifang, Shandong, China will start up in 2022 and will include one reactor line with the capability to produce 450KTA of polypropylene. The award increases the total amount of licensed volume for UNIPOL® PP technology worldwide to more than 27 million tons per annum. “Our team at Grace is excited to embark on this project with Sinochem Hongrun and welcome them to the UNIPOL® PP Family. We are committed to their success through...

HOLLISTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2021 before the market opens on May 6, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. You can access the live conference call by dialing the following phone numbers: toll-free 1 (877) 303-7611 or international 1 (970) 315-0445 and referencing the conference ID # 5876756. The conference call will be simultaneously webcast and can be accessed through the Harvard Bioscience website. To listen to the webcast, go to http://investor.harvardbioscience.com/ – Events & Presentations. Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations...

WILMINGTON, Del., April 19, 2021 (GLOBE NEWSWIRE) — InterDigital, Inc. (NASDAQ:IDCC), a mobile and video technology research and development company, today announced the nomination of Pierre-Yves Lesaicherre for election to the company’s Board of Directors at the company’s annual shareholder meeting scheduled for June 2, 2021. Dr. Lesaicherre is an executive with leading experience in semiconductors and a strong background in technology, science and global business. Dr. Lesaicherre was the President, Chief Executive Officer and Director of Nanometrics Incorporated, a leading provider of advanced process control metrology and software analytics, from 2017 to 2019. Prior to his tenure at Nanometrics, Dr. Lesaicherre was the CEO of Lumileds, an integrated manufacturer of LED components and automotive lighting lamps, starting in 2012....

MIAMI, April 19, 2021 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI) (the “Company”), will release First Quarter 2021 earnings before the start of trading on Wednesday, May 5, 2021. Management will host a conference call on May 5, 2021, at 8:30 am ET to discuss the company’s financial results. The conference call can be accessed as follows: An audio replay of the conference call will be available from approximately 11:30 am ET on May 5, 2021, until 11:59 pm ET on May 19, 2021, and can be accessed by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international), and providing the passcode 13719094 or by accessing Intermex’s website at https://investors.intermexonline.com/.  About International Money Express, Inc.At International Money Express, Inc. (NASDAQ: IMXI), the customer is at the center of everything...

ROCKVILLE, MD, April 19, 2021 (GLOBE NEWSWIRE) —  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the first quarter of 2021 after the market closes on Thursday, April 29, 2021. MacroGenics will host a conference call to discuss the financial results and recent corporate progress on Thursday, April 29, 2021 at 4:30 pm ET. The conference call can be accessed by dialing (877) 303-6253 (domestic) or (973) 409-9610 (international) five minutes prior to the start of the call and providing the Conference ID# 5257004. The listen-only webcast of the conference call can be accessed under “Events & Presentations” in the...

DALLAS, April 19, 2021 (GLOBE NEWSWIRE) — A. H. Belo Corporation (NYSE: AHC) said today that it will release first quarter 2021 financial results before the market opens on Tuesday, April 27, 2021. A conference call will be held on Tuesday, April 27, 2021 at 9:00 a.m. CDT. The conference call will be simultaneously webcast on A. H. Belo Corporation’s website at www.ahbelo.com/invest. An archive of the webcast will be available at www.ahbelo.com in the Investor Relations section. To access the listen-only conference call, dial 1-877-226-8189 and enter the following access code when prompted: 5840199. A replay line will be available at 1-866-207-1041 from 12:00 p.m. CDT on April 27, 2021 until 11:59 p.m. CDT on May 3, 2021. The access code for the replay is 8305657. About A. H. Belo Corporation A. H. Belo Corporation is the leading...

LONDON and NEW YORK, April 19, 2021 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., president and chief executive officer, and Stuart Naylor, Ph.D., chief development officer, will participate in a fireside chat at the Chardan Virtual Genetic Medicines Manufacturing Summit on Monday, April 26, 2021 at 1:45 p.m. ET. A live webcast of the presentation will be available on the Investors page of the Company’s website at www.investors.meiragtx.com. A replay of the webcast will be available for approximately 90 days following the presentation. About MeiraGTxMeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical...

BILLERICA, Mass., April 19, 2021 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a license agreement with Paragon 28, Inc., granting Paragon 28 a non-exclusive license under a subset of Conformis’ U.S. patents for the use of patient-specific instruments with off-the-shelf implants in Paragon 28’s APEX 3D™ Total Ankle Replacement System. “We are pleased to reach this agreement with Paragon 28, enabling it to incorporate our patient-specific instrument technology in its anticipated total ankle replacement offering,” said Mark Augusti, President and Chief Executive Officer. “We believe that this latest license agreement further demonstrates the broad applicability and clinical appeal of Conformis’ technology.” About Conformis, Inc. Conformis is a medical technology company that uses its proprietary...